Vitamin D3 deficiency results in dysfunctions of immunity with severe fatigue and depression in a variety of diseases

In Vivo

Volumn 28, Issue 1, 2014, Pages 133-145

  Höck, Anna Dorothea ^a  

^a Off of Int Med and Psychotherapy   (Germany)

Author keywords

Auto xenophagy; Cathelicidin; Chronic diseases; Immune imbalance; Review; Vitamin D3 deficiency

Indexed keywords

CALCIFEDIOL; CATHELICIDIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; COLECALCIFEROL;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; AUTOPHAGY; B LYMPHOCYTE ACTIVATION; CHRONIC INFLAMMATION; CYTOTOXICITY; DEPRESSION; DISEASE SEVERITY; ENDOCYTOSIS; FATIGUE; HUMAN; IMMUNE DYSREGULATION; IMMUNOMODULATION; IMMUNOREGULATION; INNATE IMMUNITY; MYELOID DENDRITIC CELL; NATURAL KILLER T CELL; NONHUMAN; PERSISTENT INFECTION; PHAGOCYTOSIS; PROTEIN SECRETION; REGULATORY T LYMPHOCYTE; REVIEW; STRESS; T LYMPHOCYTE ACTIVATION; VITAMIN D DEFICIENCY; XENOPHAGY; AUTO/XENOPHAGY; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CHRONIC DISEASES; IMMUNE IMBALANCE; INFLAMMATION; METABOLISM; PATHOLOGY;

AUTO/XENOPHAGY; CATHELICIDIN; CHRONIC DISEASES; IMMUNE IMBALANCE; REVIEW; VITAMIN D3 DEFICIENCY;

AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CHOLECALCIFEROL; DEPRESSION; FATIGUE; HUMANS; INFLAMMATION;

EID: 84906930445     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Review

References (180)

1. Adams JS, Ren S, Liu PT, Chun RF, Lagishetty V, Gombart AF, Borregaard N, Modlin RL and Hewison M: Vitamin D in defense of the human immune response. Ann NY Acad Sci 1117: 94-105, 2007.
2. Blaney GP, Albert PJ and Proal AD: Vitamin D metabolites as clinical markers in autoimmune and chronic disease. Ann NY Acad Sci 1173: 384-390, 2009.
3. Bruce D, Yu S, Ooi JH and Cantorna MT: Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. Int Immunol 23(8): 519-528, 2011.
4. Hepburn AL: Adult coeliac disease: Rheumatic presentations are common. BMJ 335(7621): 627, 2007.
5. Hewison M: Vitamin D and the immune system: New perspectives on an old theme. Endocrinol Metab Clin North Am 39(2): 365-379, 2010.
6. Holick MF and Chen TC: Vitamin D deficiency: A worldwide problem with health consequences. Am J Clin Nutr 87(4): 1080S-1086S, 2008.
7. Dev R, Del Fabbro E, Schwartz GG, Hui D, Palla SL, Gutierrez N and Bruera E: Preliminary report: Vitamin D deficiency in advanced cancer patients with symptoms of fatigue or anorexia. Oncologist 16(11): 1637-1641, 2011.
8. Antiel RM, Caudill JS, Burkhardt BE, Brands CK and Fischer PR: Iron insufficiency and hypovitaminosis D in adolescents with chronic fatigue and orthostatic intolerance. South Med J 104(8): 609-611, 2011.
9. Berkovitz S, Ambler G, Jenkins M and Thurgood S: Serum 25-hydroxy vitamin D levels in chronic fatigue syndrome: A retrospective survey. Int J Vitam Nutr Res 79(4): 250-254, 2009.
10. 3: A pilot study. Eur J Neurol 19(12): 1554-1560, 2012.
11. Gerwin RD: A review of myofascial pain and fibromyalgia-factors that promote their persistence. Acupunct Med 23(3): 121-134, 2005.
12. Höck AD. Divalent cations, hormones, psyche and soma: Four case reports. In: Chronic Fatigue Syndrome. Critical Reviews and Clinical Advances. De Meileir K and Patarca-Montero R (eds.) New York, Haworth Medical Press. pp. 117-131, 2000.
13. Hoskin L, Clifton-Bligh O, Hansen R, Fulcher G and Gates F: Bone density and body composition in young women with chronic fatigue. Ann N Y Acad Sci 904: 625-627, 2000.
14. Knutsen KV, Brekke M, Gjelstad S and Lagerløv P: Vitamin D status in patients with musculoskeletal pain, fatigue and headache: A cross-sectional descriptive study in a multi-ethnic general practice in Norway. Scand J Prim Health Care 28: 166-171, 2010.
15. McCarty DE: Resolution of hypersomnia following identification and treatment of vitamin D deficiency. J Clin Sleep Med 6(6): 605-608, 2010.
16. Shinchuk LM and Holick MF: Vitamin D and rehabilitation: Improving functional outcomes. Nutr Clin Pract 22(3): 297-304, 2007.
17. Adams JS and Hewison M: Update in Vitamin D. J Clin Endocrinol Metab 95: 471-478, 2010.
18. Christakos S, Dhawan P, Porta A, Mady LJ and Seth T: Vitamin D and intestinal calcium absorption. Mol Cell Endocrinol 347(1-2): 25-29, 2011.
19. Chun RF, Adams JS and Hewison M: Back to the future: A new look at 'old' vitamin D. J Endocrinol 198(2): 261-269, 2008.
20. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC and Jurutka PW. Nuclear vitamin D receptor: natural ligands, molecular structure-function, and transcriptional control of vital genes. In: Vitamin D. Third edition. Feldman D, Pike JW and Adams JS (eds.). New York, Academic Press, pp. 137-170, 2011.
21. Morris H A and Anderson PH: Autocrine and paracrine actions of vitamin D. Clin Biochem Rev 31: 129-138, 2010.
22. Peterlik M and Cross HS: Vitamin D and calcium insufficiency-related chronic diseases: Molecular and cellular pathophysiology. Eur J Clin Nutr 63(12): 1377-1386, 2009.
23. Mizwicki MT and Norman AW. Vitamin D sterol/VDR conformational dynamics and nongenomic actions. In: Vitamin D. Third edition. Feldman D, Pike JW and Adams JS (eds.). New York, Academic Press, pp. 271-297, 2011.
24. Norman AW: Minireview: New assignments for an already busy receptor. Endocrinology 147(12): 5542-5548, 2006.
25. 3. Rheum Dis Clin North Am 38(1): 13-27, 2012.
26. Hewison M: Vitamin D and the intracrinology of innate immunity. Mol Cell Endocrinol 321(2): 103-111, 2010.
27. Kamen DL: Vitamin D and molecular actions on the immune system: Modulation of innate and autoimmunity. J Mol Med (Berl) 88(5): 441-450, 2010.
28. Liu PT: The role of vitamin D in innate immunity: antimicrobial activity, oxidative stress, and barrier function. In: Vitamin D. Third edition. Feldman D, Pike JW and Adams JS (eds.) New York, Academic Press, pp. 1811-1823, 2011.
29. White JH. Vitamin D and innate immunity. In: Vitamin D. Third edition. Feldman D, Pike JW and Adams JS (eds.). New York, Academic Press, pp. 1777-1787, 2011.
30. 2+ absorption between enterocytes. Mol Biol Cell 19(5): 1912-1921, 2008.
31. Kong J, Zhang Z, Musch MW, Ning G, Sun J, Hart J, Bissonnette M and Li YC: Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 294(1): G208-G216, 2008.
32. Sun J: Vitamin D and mucosal immune function. Curr Opin Gastroenterol 26(6): 591-595, 2010.
33. Ramot Y, Paus R, Tiede S and Zlotogorsky A: Endocrine controls of keratin expression. Bioassays 31(4): 389-399, 2009.
34. 3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation. J Invest Dermatol 128(9): 2271-2280, 2008.
35. Miodovnik M, Koren R, Ziv E and Ravid A: The inflammatory response of keratinocytes and its modulation by vitamin D: The role of MAPK signaling pathways. J Cell Physiol 227(5): 2175-2183, 2012.
36. Bahar-Shany K, Ravid A and Koren R: Up-regulation of MMP-9 production by TNFα in keratinocytes and its attenuation by vitamin D. J Cell Physiol 222(3): 729-737, 2010.
37. Langberg M, Rotem C, Fenig E, Koren R and Ravid A: Vitamin D protects keratinocytes from deleterious effects of ionizing radiation. Br J Dermatol 160(1): 151-161, 2009.
38. Diker-Cohen T, Koren R and Ravid A: Programmed cell death of stressed keratinocytes and its inhibition by vitamin D: The role of death and survival signaling pathways. Apoptosis 11(4): 519-534, 2006.
39. 3 acts directly on human lymphocytes and interferes with the cellular response to interleukin-2. Immunopharmacology 18(3): 187-194, 1989.
40. Gombart AF: The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiol 4(9): 1151-1165, 2009.
41. Agerberth B, Charo J, Werr J, Olsson B, Idali F, Lindbom L, Kiessling R, Jörnvall H, Wigzell H and Gudmundsson GH: The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96(9): 3086-3093, 2000.
42. Alalwani SM, Sierigk J, Herr C, Pinkenburg O, Gallo R, Vogelmeier C and Bals R: The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils. Eur J Immunol 40(4): 1118-1126, 2010.
43. Cederlund A, Gudmundsson GH and Agerberth B: Antimicrobial peptides important in innate immunity. FEBS J 278(20): 3942-3951, 2011.
44. Kai-Larsen Y and Agerberth B: The role of the multifunctional peptide LL-37 in host defense. Front Biosci 13: 3760-3767, 2008.
45. Yang D, Chertov O and Oppenheim JJ: The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adoptive immunity. Cell Mol Life Sci 58(7): 978-989, 2001.
46. Allaker RP: Host defence peptides-A bridge between the innate and adaptive immune responses. Trans R Soc Trop Med Hyg 102(1): 3-4, 2008.
47. Bowdish DM, Davidson DJ and Hancock RE: Immunomodulatory properties of defensins and cathelicidins. Curr Top Microbiol Immunol 306: 27-66, 2006.
48. Büchau AS, Morizane S, Trowbridge J, Schauber J, Kotol P, Bui JD and Gallo RL: The host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growth. J Immunol 184(1): 369-378, 2010.
49. Campbell GR and Spector SA: Autophagy induction by vitamin D inhibits both Mycobacterium tuberculosis and human immunodeficiency virus type 1. Autophagy 8(10): 1523-1525, 2012.
50. Di Rosa M, Malaguarnera M, Nicoletti F and Malaguarnera L: Vitamin D3: A helpful immune-modulator. Immunology 134(2): 123-139, 2011.
51. McGillivray SM, Ebrahimi CM, Fisher N, Sabet M, Zhang DX, Chen Y, Haste NM, Aroian RV, Gallo RL, Guiney DG, Friedlander AM, Koehler TM and Nizet V: ClpX contributes to innate defense peptide resistance and virulence phenotypes of Bacillus anthracis. J Innate Immun (5): 494-506, 2009.
52. Fabri M, Stenger S, Shin DM, Yuk JM, Liu PT, Realegeno S, Lee HM, Krutzik SR, Schenk M, Sieling PA, Teles R, Montoya D, Iyer SS, Bruns H, Lewinsohn DM, Hollis BW, Hewison M, Adams JS, Steinmeyer A, Zügel U, Cheng G, Jo EK, Bloom BR and Modlin RL: Vitamin D is required for IFN-γ-mediated antimicrobial activity of human macrophages. Sci Transl Med 3(104): 104ra102, 2011.
53. 3 and cytokines. J Leukoc Biol 58(2): 256-262, 1995.
54. Maliszewski CR, Shen L and Fanger MW: The expression of receptors for IgA on human monocytes and calcitriol-treated HL-60 cells. J Immunol 135(6): 3878-3881, 1985.
55. Shen L, Maliszewski CR, Rigby WF and Fanger MW: IgA-mediated effector function of HL-60 cells following treatment with calcitriol. Mol Immunol 23(6): 611-618, 1986.
56. Adorini L: Control of adaptive immunity by vitamin D receptor agonists. In: Vitamin D. Third edition. Feldman D, Pike JW and Adams JS (eds.). New York, Academic Press, pp. 1789-1809, 2011.
57. 3 induces CCR10 expression in terminally differentiating human B-cells. J Immunol 180(5): 2786-2795, 2008.
58. Deretic V and Levine B: Autophagy, immunity, and microbial adaptations. Cell Host Microbe 5(6): 527-549, 2009.
59. Deretic V: Autophagy as an innate immunity paradigm: Expanding the scope and repertoire of pattern recognition receptors. Curr Opin Immunol 24(1): 21-31, 2012.
60. Kroemer G, Mariño G and Levine B: Autophagy and the integrated stress response. Mol Cell 40(2): 280-293, 2010.
61. Mehrpour M, Esclatine A, Beau I and Codogno P: Autophagy in health and disease. 1. Regulation and significance of autophagy: An overview. Am J Physiol Cell Physiol 298: C776-C785, 2010.
62. Oh JE and Lee HK: Autophagy in innate recognition of pathogens and adaptive immunity. Yonsei Med J 53(2): 241-247, 2012.
63. Levine B and Kroemer G: Autophagy in the pathogenesis of disease. Cell 132(1): 27-42, 2008.
64. Wu S and Sun J: Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection. Discov Med 11(59): 325-335, 2011.
65. Choi AMK, Ryter SW and Levine B: Autophagy in human health and disease. N Engl J Med 368(7): 651-661, 2013.
66. Høyer-Hansen M, Bastholm L, Mathiasen IS, Elling F and Jäättelä M: Vitamin D analog EB1089 triggers dramatic lysosomal changes and beclin 1-mediated autophagic cell death. Cell Death Differentiation 12: 1297-1309, 2005.
67. Høyer-Hansen M: AMP-activated protein kinase. A universal regulator of autophagy. Autophagy 3(4): 381-383, 2007.
68. Glick D, Barth S and Macleod KF: Autophagy: Cellular and molecular mechanisms. J Pathol 221(1): 3-12, 2010.
69. He M-X, MacLeod IX, Jia W and He Y-W: Macroautophagy in T lymphocyte development and function. Front Immunol 3: 22, 2012
70. Ligeon LA, Temime-Smaali N and Lafont F: Ubiquitylation and autophagy in the control of bacterial infections and related responses. Cell Microbiol 13(9): 1303-1311, 2011.
71. Nedjic J, Aichinger M and Klein L: Autophagy and T cell education in the thymus: Eat yourself to know yourself. Cell Cycle 7(23): 3625-3628, 2008.
72. Winiarska M, Bil J, Nowis D and Golab J: Proteolytic pathways involved in modulation of CD20 levels. Autophagy 6(6): 810-812, 2010.
73. Travassos LH, Carneiro LA, Girardin S and Philpott DJ: Nod proteins link bacterial sensing and autophagy. Autophagy 6(3): 409-411, 2010.
74. 3-phosphoinositide 3-kinase pathway. J Cell Sci 117: 2131-2139, 2004.
75. 3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 6(3): 231-243, 2009.
76. Wang J: Beclin 1 bridges autophagy, apoptosis and differentiation. Autophagy 4(7): 947-948, 2008.
77. Liang C: Negative regulation of autophagy. Cell Death Differ 17(12): 1807-1815, 2010.
78. Chandra G, Selvaraj P, Jawahar MS, Banurekha VV and Narayanan PR: Effect of vitamin D 3 on phagocytic potential of macrophages with live Mycobacterium tuberculosis and lymphoproliferative response in pulmonary tuberculosis. J Clin Immunol 24(3): 249-257, 2004.
79. Abu-Amer Y and Bar-Shavit Z: Impaired bone marrow-derived macrophage differentiation in vitamin D deficiency. Cell Immunol 151(2): 356-368, 1993.
80. 3 curtails the inflammatory and T-cell-stimulatory capacity of macrophages through an IL-10-dependent mechanism. Immunobiology 217(12): 1292-1300, 2012.
81. 3 stimulates phagocytosis but suppresses HLA-DR and CD13 antigen expression in human mononuclear phagocytes. Proc Soc Exp Biol Med 211(3): 244-250, 1996.
82. Zughaier SM, Shafer WM and Stephens DS: Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages. Cell Microbiol 7(9): 1251-1262, 2005.
83. Blanco P, Palucka AK, Pascual V and Banchereau J: Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev 19(1): 41-52, 2008.
84. Kushwa R and Hu J: Role of dendritic cells in the induction of regulatory T-cells. Cell Biosci 1(1): 20, 2011.
85. Steinman RM, Hawiger D, Liu K, Bonifaz L, Bonnyay D, Mahnke K, Iyoda T, Ravetch J, Dhodapkar M, Inaba K and Nussenzweig M: Dendritic cell function in vivo during the steady state: A role in peripheral tolerance. Ann NY Acad Sci 987: 15-25, 2003.
86. Singh VK, Mehrotra S and Agarwal SS: The paradigm of Th1 and Th2 cytokines. Its relevance to autoimmunity and allergy. Immunol Res 20: 147-161, 1999.
87. Alberts B, Johnson A, Lewis J, Raff M, Roberts K and Walter P. The adaptive immune system. In: Molecular Biology of the Cell. Anderson M and Granum S (eds.). New York, Garland Science, pp. 1539-1601, 2008.
88. 3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol 145(3): 351-357, 2001.
89. Adler HS and Steinbrink K: Tolerogenic dendritic cells in health and disease: Friend and foe! Eur J Dermatol 17(6): 476-491, 2007.
90. Sloka S, Silva C, Wang J and Yong VW: Predominance of Th2 polarization by vitamin D through a STAT6-dependent mechanism. J Neuroinflammation 8: 56, 2011.
91. 3 and Interleukin-2 combine to inhibit T-cell production of inflammatory cytokines and promote development of regulatory T-cells expressing CTLA-4 and FOXP3. J Immunol 183(9): 5458-5467, 2009.
92. Afzali B, Mitchell P, Lechler RI, John S and Lombardi G: Translational mini-review series on Th17 cells: Induction of interleukin-17 production by regulatory T-cells. Clin Exp Immunol 159(2): 120-130, 2010.
93. Prietl B, Pilz S, Wolf M, Tomaschitz A, Obermayer-Pietsch B, Graninger W and Pieber TR: Vitamin D supplementation and regulatory T-cells in apparently healthy subjects: Vitamin D treatment for autoimmune diseases? Isr Med Assoc J 12(3): 136-139, 2010.
94. Peterson RA: Regulatory T-cells: Diverse phenotypes integral to immune homeostasis and suppression. Toxicol Pathol 40(2): 186-204, 2012.
95. Schmidt SV, Nino-Castro AC and Schultze JL: Regulatory dendritic cells: There is more than just immune activation. Front Immunol 3: 274, 2012.
96. Mahnke K, Ring S, Bedke T, Karakhanova S and Enk AH: Interaction of regulatory T-cells with antigen-presenting cells in health and disease. Chem Immunol Allergy 94: 29-39, 2008.
97. + T-cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis. J Clin Invest 120(9): 3242-3254, 2010.
98. von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Odum N and Geisler C: Vitamin D controls T-cell antigen receptor signaling and activation of human T-cells. Nat Immunol 11(4): 344-349, 2010.
99. 3 on the cytokine production of human peripheral blood lymphocytes. J Clin Endocrinol Metab 84(10): 3739-3744, 1999.
100. Cantorna MT: Why do T-cells express the vitamin D receptor? Ann NY Acad Sci 1217: 77-82, 2011.
101. Chang SH, Chung Y and Dong C: Vitamin D suppresses Th17 cytokine production by inducing C/EBP homologous protein (CHOP) expression. J Biol Chem 285(50): 38751-3855, 2010.
102. Joshi S, Pantalena LC, Liu XK, Gaffen SL, Liu H, Rohowsky-Kochan C, Ichiyama K, Yoshimura A, Steinman L, Christakos S and Youssef S: 1,25-Dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol 31(17): 3653-3669, 2011.
103. 3 promotes CD200 expression by human peripheral and airway-resident T cells. Thorax 67(7): 574-581, 2012.
104. 3 in activated murine dendritic cells can function as effective mucosal adjuvants to subcutaneously administered vaccines. Vaccine 26(5): 601-613, 2008.
105. 3 enhances systemic and mucosal immune responses to inactivated poliovirus vaccine in mice. J Infect Dis 193(4): 598-600, 2006.
106. Yu S, Bruce D, Froicu M, Weaver V and Cantorna MT: Failure of T-cell homing, reduced CD4/CD8αα intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice. Proc Natl Acad Sci USA 105(52): 20834-20839, 2008.
107. Kim SY, Suh HW, Chung JW, Yoon SR and Choi I: Diverse functions of VDUP1 in cell proliferation, differentiation, and diseases. Cell Mol Immunol 4(5): 345-351, 2007.
108. Fallarino F and Grohmann U: Using an ancient tool for igniting and propagating immune tolerance: IDO as an inducer and amplifier of regulatory T-cell functions. Curr Med Chem 18(15): 2215-2221, 2011.
109. Delgado M: Generating tolerogenic dendritic cells with neuropeptides. Hum Immunol 70(5): 300-307, 2009.
110. Spadoni I, Iliev ID, Rossi G and Rescigno M: Dendritic cells produce TSLP that limits the differentiation of Th17 cells, fosters Treg development, and protects against colitis. Mucosal Immunol (2): 184-193, 2012.
111. Clark DA: Tolerance signaling molecules. Chem Immunol Allergy 89: 36-48, 2005.
112. Strowig T, Brilot F and Münz C: Non-cytotoxic functions of natural killer cells: Direct pathogen restriction and assistance to adaptive immunity. J Immunol 180(12): 7785-7791, 2008.
113. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM and Ugolini S: Innate or adaptive immunity? The example of natural killer cells. Science 331(6013): 44-49, 2011.
114. Brady J, Carotta S, Thong RP, Chan CJ, Hayakawa Y, Smyth MJ and Nutt SL: The interactions of multiple cytokines control NK cell maturation. J Immunol 185(11): 6679-6688, 2010.
115. Souza-Fonseca-Guimaraes F, Adib-Conquy M and Cavaillon JM: Natural killer (NK) cells in antibacterial innate immunity: angels or devils? Mol Med 18: 270-285, 2010.
116. Walzer T, Dalod M, Robbins SH, Zitvogel L and Vivier E: Natural-killer cells and dendritic cells: "l'union fait la force". Blood 106(7): 2252-2258, 2005.
117. 3 increases cytotoxicity and exocytosis in lymphokine-activated killer cells. Mol Cell Endocrinol 96(1-2): 133-139, 1993.
118. Zafirova B, Wensveen FM, Gulin M and Polić B: Regulation of immune cell function and differentiation by the NKG2D receptor. Cell Mol Sci 68: 3519-3529, 2011.
119. Jamil KM and Khakoo SI: KIR/HLA interactions and pathogenic immunity. J Biomed Biotech 2011: 298348, 2011.
120. Ben-Eliyahu S: Can we really know if a stressor increases or decreases natural killer cell activity? Brain Behav Immun 26(8): 1224-1225, 2012.
121. Meron G, Tishler Y, Shaashua L, Rosenne E, Levi B, Melamed R, Gotlieb N, Matzner P, Sorski L and Ben-Eliyahu S: PGE(2) suppresses NK activity in vivo directly and through adrenal hormones: Effects that cannot be reflected by ex vivo assessment of NK cytotoxicity. Brain Behav Immun 28: 128-138, 2013.
122. Lemire JM: Immunomodulatory role of 1,25-Dihydroxyvitamin D3. J Cell Biochem 49(1): 26-31, 1992.
123. Kaneno R, Duarte AJ and Borelli A: Natural killer activity in the experimental privational rickets. Immunol Lett 81(3): 183-189, 2002.
124. 3. Scand J Immunol 30(2): 199-208, 1989.
125. Rebut-Bonneton C and Demignon J: Effect of calcitriol on peripheral blood lymphocyte cytotoxicity. Biomed Pharmacother 45(8): 369-372, 1991.
126. 3: A possible NK-eosinophil crosstalk via IL-8 in the pathophysiology of allergic rhinitis. Mediat Inflamm 2011: 373589, 2011.
127. 3. Cell Immunol 118(2): 328-336, 1989.
128. 3 enhances the up-regulation of interleukin-2 receptor (p55) by interleukin-2. Nihon Ketsueki Gakkai Zasshi 52(6): 996-1003, 1989.
129. Quesada JM, Serrano I, Borrego F, Martin A, Peña J and Solana R: Calcitriol effect on natural killer cells from hemodialyzed and normal subjects. Calcif Tissue Int 56(2): 113-117, 1995.
130. 3 regulates the synthesis of γ-glutamyl transpeptidase and glutathione levels in rat primary astrocytes. J Neurochem 73(2): 859-866, 1999.
131. Kechrid Z, Hamdi M, Naziroʇlu M and Flores-Arce M: Vitamin D supplementation modulates blood and tissue zinc, liver glutathione and blood biochemical parameters in diabetic rats on a zinc-deficient diet. Biol Trace Elem Res 148(3): 371-377, 2012.
132. 2-vitamin D(3) on the activation of natural killer cells: Role of protein kinase C and extracellular calcium. Exp Mol Pathol 67(2): 63-74, 1999.
133. Lee KN, Kang HS, Jeon JH, Kim EM, Yoon SR, Song H, Lyu CY, Piao ZH, Kim SU, Han YH, Song SS, Lee YH, Song KS, Kim YM, Yu DY and Choi I: VDUP1 is required for the development of natural killer cells. Immunity 22(2): 195-208, 2005.
134. Issazadeh-Navikas S: NKT cell self-reactivity: Evolutionary master key of immune homeostasis? J Mol Cell Biol 4(2): 70-78, 2012.
135. Juno JA, Keynan Y and Fowke KR: Invariant NKT cells: Regulation and function during viral infection. PLOS Pathogens 8(8): e1002838, 2012.
136. Cantorna MT: Mechanisms underlying the effect of vitamin D on the immune system. Proc Nutr Soc 69(3): 286-289, 2010.
137. Yassai M, Cooley B and Gorski J: Developmental dynamics of post-selection thymic DN iNKT. PLoS One 7(8): e43509, 2012.
138. Yu S and Cantorna MT: The vitamin D receptor is required for iNKT cell development. Nat Acad Sci USA 105(13): 5207-5212, 2008.
139. Yue X, Izcue A and Borggrefe T: Essential role of mediator subunit MED 1 in invariant natural killer T-cell development. Proc Natl Acad Sci USA 108(41): 17105-17110, 2011.
140. Bendelac A, Savage PB and Teyton L: The biology of NKT cells. Annu Rev Immunol 25: 297-336, 2007.
141. Brennan PJ, Tatituri RVV, Brigl M, Kim EY, Tuli A, Sanderson JP, Gadola SD, Hsu FF, Besra GS and Brenner MB: Invariant natural killer T-cells recognize lipid self-antigen induced by microbial danger signals. Nat Immunol 12(12): 1202-1211, 2012.
142. Morgan JW, Morgan DM, Lasky SR, Ford D, Kouttab N and Maizel AL: Requirements for induction of vitamin D-mediated gene regulation in normal human B-lymphocytes. J Immunol 157(7): 2900-2908, 1996.
143. Cecere TE, Todd SM and LeRoith T: Regulatory T-cells in Arterivirus and Coronavirus infections: Do they protect against disease or enhance it? Viruses 4: 833-846, 2012.
144. Pappworth IY, Wang EC and Rowe M: The switch from latent to productive infection in Epstein-Barr virus-infected B-cells is associated with sensitization to NK cell killing. J Virol 81(2): 474-482, 2007.
145. Subleski JJ, Jiang Q, Weiss JM and Wiltrout RH: The split personality of NKT cells in malignancy, autoimmune and allergic disorders. Immunotherapy 3(10): 1167-1184, 2011.
146. Watarai H, Sekine-Kondo E, Shigeura T, Motomura Y, Yasuda T, Satoh R, Yoshida H, Kubo M, Kawamoto H, Koseki H and Taniguchi M: Development and function of natural killer T-cells producing TH2- and TH17-cytokines. PLoS Biology 10(2): e1001255, 2012.
147. + cytotoxic T-cell responses by inducing CD70 expression on dendritic cells. J Immunol 180(7): 4615-4620, 2008.
148. Parietti V, Chifflot H, Sibilia J, Muller S and Monneaux F: Rituximab treatment overcomes reduction of regulatory iNKT cells in patients with rheumatoid arthritis. Clin Immunol 134(3): 331-339, 2010.
149. Ooi JH, Chen J and Cantorna MT: Vitamin D regulation of immune function in the gut: Why do T-cells have vitamin D receptors? Mol Aspects Med 33(1): 77-82, 2012.
150. Yu S and Cantorna MT: Epigenetic reduction in iNKT cells following in utero vitamin D deficiency in mice. J Immunol 186(3): 1384-1390, 2011.
151. Gordy LE, Bezbradica JS, Flyak AI, Spencer CT, Dunkle A, Sun J, Stanic AK, Boothby MR, He YW, Zhao Z, Van Kaer L and Joyce S: IL-15 regulates homeostasis and terminal maturation of NKT cells. J Immunol 187(12): 6335-6345, 2011.
152. Ma LJ, Acero LF, Zal T and Schluns K: Trans-presentation of IL-15 by intestinal epithelial cells drives development of CD8αα IELs. J Immunol 183(2): 1044-1054, 2009.
153. Gao J, Ma X, Gu W, Fu M, An J, Xing Y, Gao T, Li W and Liu Y: Novel functions of murine B1 cells: Active phagocytic and microbicidal abilities. Eur J Immunol 42(4): 982-992, 2012.
154. Qian L, Qian C, Chen Y, Bai Y, Bao Y, Lu L and Cao X: Regulatory dendritic cells program B-cells to differentiate into CD19hiFcγIIbhi regulatory B-cells through IFN-β and CD40L. Blood 120(3): 581-591, 2012.
155. Kin NW, Chen Y, Stefanov EK, Gallo RL and Kearney JF: Cathelin-related antimicrobial peptide differentially regulates T- and B-cell function. Eur J Immunol 41(10): 3006-3016, 2011.
156. Wuerth K and Hancock RE: New insights into cathelicidin modulation of adaptive immunity. Eur J Immunol 41(10): 2817-2819, 2011.
157. 3 on human B-cell differentiation. J Immunol 179: 1634-1647, 2007.
158. 3 impairs NF-kB activation in human naïve B-cells. Biochem Biophys Res Commun 407(4): 699-702, 2011.
159. Galli G, Pittoni P, Tonti E, Malzone C, Uematsu Y, Tortoli M, Maione D, Volpini G, Finco O, Nuti S, Tavarini S, Dellabona P, Rappuoli R, Casorati G and Abrignani S: Invariant NKT cells sustain specific B-cell responses and memory. Proc Natl Acad Sci USA 104(10): 3984-3989, 2007.
160. Enoksson SL, Grasset EK, Hägglöf T, Mattsson N, Kaiser Y, Gabrielsson S, McGaha TL, Scheynius A and Karlsson MC: The inflammatory cytokine IL-18 induces self-reactive innate antibody responses regulated by natural killer T-cells. Proc Natl Acad Sci USA 108(51): E1399-1407, 2011.
161. Tonti E, Fedeli M, Napolitano A, Iannacone M, von Andrian UH, Guidotti LG, Abrignani S, Casorati G and Dellabona P: Follicular helper NKT cells induce limited B-cell responses and germinal center formation in the absence of CD4(+) T-cell help. J Immunol 188(7): 3217-3222, 2012.
162. Wen X, Yang JQ, Kim PJ and Singh RR: Homeostatic regulation of marginal zone B-cells by invariant natural killer T-cells. PLoS One 6(10): e26536, 2011.
163. Yang JQ, Wen X, Kim PJ and Singh RR: Invariant NKT cells inhibit autoreactive B-cells in a contact- and CD1d-dependent manner. J Immunol 186(3): 1512-1520, 2011.
164. Bialecki E, Paget C, Fontaine J, Capron M, Trottein F and Faveeuw C: Role of marginal zone B-lymphocytes in invariant NKT cell activation. J Immunol 182(10): 6105-6113, 2009.
165. + B-cells is essential for the maintenance of invariant natural killer T-cells. Immunity 36(3): 477-490, 2012.
166. Sinha A, Hollingsworth KG, Ball S and Cheetham T: Improving the vitamin D status of vitamin D-deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle. J Clin Endocrinol Metab 98(3): E509-513, 2013.
167. Rossi AE, Boncompagni S and Dirksen RT: Sarcoplasmic reticulum-mitochondrial symbiosis: Bi-directional signaling in skeletal muscle. Exerc Sport Sci Rev 37(1): 29-35, 2009.
168. Bergman P, Lindh AU, Björkhem-Bergman L and Lindh JD: Vitamin D and respiratory tract infections: A systematic review and meta-analysis of randomized controlled trials. PLoS One 8(6): e65835, 2013.
169. 3 supplementation in patients with frequent respiratory tract infections: A randomised and double-blind intervention study. BMJ Open 2(6): e001663, 2012.
170. Pfeffer PE and Hawrylowicz CM: Vitamin D and lung disease. Thorax 67(11): 1018-1020, 2012.
171. Décard BF, von Ahsen N, Grunwald T, Streit F, Stroet A, Niggemeier P, Schottstedt V, Riggert J, Gold R and Chan A: Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis. J Neurol Neurosurg Psychiatry 83(12): 1170-1173, 2012.
172. Mealy MA, Newsome S, Greenberg BM, Wingerchuk D, Calabresi P and Levy M: Low serum vitamin D levels and recurrent inflammatory spinal cord disease. Arch Neurol 69(3): 352-356, 2012.
173. Simon KC, Munger KL and Ascherio A: Vitamin D and multiple sclerosis: Epidemiology, immunology, and genetics. Curr Opin Neurol 25(3): 246-251, 2012.
174. Smolders J, Schuurman KG, van Strien ME, Melief J, Hendrickx D, Hol EM, van Eden C, Luchetti S and Huitinga I: Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue. J Neuropathol Exp Neurol 72(2): 91-105, 2013.
175. 3 levels in patients with systemic lupus erythematosus and its association with clinical parameters and laboratory tests. Rev Bras Reumatol 52(1): 60-65, 2012.
176. Eichhorn A, Lochner S and Belz GG: Vitamin D for prevention of diseases? Dtsch Med Wochenschr 137(17): 906-912, 2012. (in German)
177. Woloszynska-Read A, Johnson CS and Trump DL: Vitamin D and cancer: Clinical aspects. Best Pract Res Clin Endocrinol Metab 25(4): 605-615, 2011.
178. Penna-Martinez M, Ramos-Lopez E, Stern J, Kahles H, Hinsch N, Hansmann ML, Selkinski I, Grünwald F, Vorländer C, Bechstein WO, Zeuzem S, Holzer K and Badenhoop K: Impaired vitamin D activation and association with CYP24A1 haplotypes in differentiated thyroid carcinoma. Thyroid 22(7): 709-716, 2012.
179. 3 in patients with ovarian cancer and its correlation with survival. Clin Biochem 45(18): 1568-1572, 2012.
180. Abou-Raya A, Abou-Raya S and Helmii M: The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: A randomized placebo-controlled trial. J Rheumatol 40(3): 265-272, 2013.